HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Dong Selected Research

salecan

2/2019Development of photocrosslinked salecan composite hydrogel embedding titanium carbide nanoparticles as cell scaffold.
1/2017Redox/pH dual stimuli-responsive degradable Salecan-g-SS-poly(IA-co-HEMA) hydrogel for release of doxorubicin.
10/2012Protective effects of salecan against carbon tetrachloride-induced acute liver injury in mice.
9/2011Results of a 90-day safety assessment study in mice fed a glucan produced by Agrobacterium sp. ZX09.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Dong Research Topics

Disease

115Neoplasms (Cancer)
06/2022 - 04/2006
27Hepatocellular Carcinoma (Hepatoma)
06/2022 - 05/2006
22Neoplasm Metastasis (Metastasis)
05/2022 - 03/2007
20Inflammation (Inflammations)
06/2022 - 02/2008
19Infections
01/2021 - 12/2011
17Carcinogenesis
11/2021 - 12/2008
16Hypoxia (Hypoxemia)
01/2022 - 02/2009
15Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 10/2013
12Heart Failure
10/2022 - 10/2004
12Wounds and Injuries (Trauma)
09/2022 - 02/2008
12Fibrosis (Cirrhosis)
08/2022 - 01/2010
12Acute Coronary Syndrome
10/2021 - 10/2004
12Urinary Bladder Neoplasms (Bladder Cancer)
03/2021 - 10/2018
11Myocardial Infarction
02/2022 - 10/2004
11Reperfusion Injury
11/2021 - 01/2010
11Colorectal Neoplasms (Colorectal Cancer)
08/2020 - 11/2008
10Stomach Neoplasms (Stomach Cancer)
02/2022 - 08/2008
10Ischemia
01/2022 - 09/2005
9Hemorrhage
03/2022 - 09/2009
9Lung Neoplasms (Lung Cancer)
01/2021 - 02/2013
9Carcinoma (Carcinomatosis)
07/2019 - 06/2011
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 06/2011
8Diabetic Nephropathies (Diabetic Nephropathy)
12/2021 - 01/2013
8Breast Neoplasms (Breast Cancer)
10/2021 - 03/2014
8Hypertension (High Blood Pressure)
10/2021 - 05/2007
7Necrosis
05/2022 - 01/2009
7Adenocarcinoma of Lung
01/2022 - 04/2010
7Pain (Aches)
01/2022 - 06/2013
7Weight Loss (Weight Reduction)
10/2020 - 01/2012
6ST Elevation Myocardial Infarction
02/2022 - 10/2004
6Osteoporosis
01/2022 - 01/2012
6Body Weight (Weight, Body)
01/2022 - 09/2011
6Lymphatic Metastasis
05/2021 - 11/2011
6Stroke (Strokes)
01/2021 - 01/2007
5Alzheimer Disease (Alzheimer's Disease)
07/2022 - 01/2018
5Liver Neoplasms (Liver Cancer)
05/2022 - 08/2008
5Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2021 - 01/2010
5Diabetes Mellitus
10/2021 - 02/2008
5Chronic Renal Insufficiency
10/2021 - 03/2017
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2019 - 01/2010
5Shock
01/2013 - 10/2004
4Thrombosis (Thrombus)
06/2022 - 01/2017
4Non-alcoholic Fatty Liver Disease
04/2022 - 07/2020
4Infarction (Infarctions)
02/2022 - 11/2015
4Heart Diseases (Heart Disease)
12/2021 - 07/2012
4Acute Kidney Injury (Acute Renal Failure)
01/2021 - 02/2018
4Pituitary Neoplasms (Pituitary Adenoma)
10/2019 - 07/2010
4Human Influenza (Influenza)
11/2018 - 06/2012
4Chronic Obstructive Pulmonary Disease (COPD)
05/2018 - 07/2011
4Cerebral Hemorrhage
11/2017 - 06/2014

Drug/Important Bio-Agent (IBA)

46Proteins (Proteins, Gene)FDA Link
06/2022 - 12/2008
22MicroRNAs (MicroRNA)IBA
01/2022 - 07/2011
17Biological ProductsIBA
03/2020 - 02/2008
16Messenger RNA (mRNA)IBA
01/2022 - 02/2003
16Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2009
13CytokinesIBA
01/2022 - 11/2010
13Circular RNAIBA
01/2022 - 10/2018
13omega-Chloroacetophenone (Mace)IBA
10/2021 - 10/2013
13Pharmaceutical PreparationsIBA
01/2021 - 04/2010
11EnzymesIBA
12/2021 - 08/2002
10Long Noncoding RNAIBA
02/2022 - 10/2016
10Small Interfering RNA (siRNA)IBA
01/2021 - 03/2007
9RNA (Ribonucleic Acid)IBA
01/2021 - 04/2010
8DNA (Deoxyribonucleic Acid)IBA
06/2022 - 11/2006
8Therapeutic UsesIBA
11/2020 - 04/2011
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 04/2010
7Immunoglobulin G (IgG)IBA
01/2021 - 12/2013
6Glucose (Dextrose)FDA LinkGeneric
04/2022 - 11/2018
6HydrogelsIBA
03/2022 - 04/2015
6AntibodiesIBA
06/2018 - 02/2007
5LipidsIBA
05/2022 - 10/2004
5Amino AcidsFDA Link
01/2022 - 01/2012
5Indicators and Reagents (Reagents)IBA
11/2021 - 02/2003
5Blood Glucose (Blood Sugar)IBA
01/2021 - 11/2013
5Phosphates (Orthophosphate)IBA
11/2014 - 10/2012
5salicylhydroxamic acid (SHAM)IBA
01/2013 - 01/2011
4Doxorubicin (Adriamycin)FDA LinkGeneric
05/2022 - 04/2015
4Immunoglobulins (Immunoglobulin)IBA
01/2022 - 12/2013
4Sorafenib (BAY 43-9006)FDA Link
01/2022 - 08/2018
4Cytochrome P-450 CYP2E1 (CYP2E1)IBA
12/2021 - 05/2011
4VaccinesIBA
04/2021 - 05/2006
4Transcription Factors (Transcription Factor)IBA
01/2021 - 02/2012
4Insulin (Novolin)FDA Link
01/2021 - 03/2015
4Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 10/2010
4Diphosphonates (Bisphosphonates)IBA
12/2020 - 01/2012
4Cadherins (E-Cadherin)IBA
01/2020 - 06/2011
4Protein CIBA
01/2020 - 01/2013
4AcidsIBA
10/2019 - 01/2012
4salecanIBA
02/2019 - 09/2011
4ImmunosorbentsIBA
01/2019 - 08/2002
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2018 - 04/2014
4Caspase 3 (Caspase-3)IBA
04/2017 - 01/2013
4figitumumabIBA
04/2017 - 10/2014
4Peptide Hydrolases (Proteases)FDA Link
01/2017 - 11/2010

Therapy/Procedure

42Therapeutics
10/2022 - 10/2004
8Radiotherapy
01/2020 - 02/2014
7Ligation
01/2022 - 02/2007
7Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 02/2009
6Drug Therapy (Chemotherapy)
05/2022 - 09/2009
4Percutaneous Coronary Intervention
02/2022 - 06/2015